Journals / Clinical and Experimental Health Sciences / 2011 / Cilt: 1 - Sayı: 1

A therapeutic role of chemical agents in experimental interstitial cystitis models

Deneysel interstisyel sistit modellerinde kimyasal ajanların tedavi edici rolü

Pages
57–64
Publication Date
2014-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The chemical agents used in those experimental studies are promising for the future treatment models in IC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Experimental interstitial cystitis (IC) models can be set as intravesical installations of chemical substances such as protamin sulfate, systemic application of chemical substances such as lipopolysaccharides, or environmental stress stimulation like cold, acute/chronic stress models.
📊
Key Findings & Data:In the studies regarding IC besides denervation of afferent nerve fibers, several antioxidant agents demonstrated a prominent regeneration as inactivation of mast cells, reconstitution of leaky tight junctions in urothelium.
💡
Conclusion & Impact:The chemical agents used in those experimental studies are promising for the future treatment models in IC.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Deneysel · interstisyel sistit · mast hücresi

Abstract

Experimental interstitial cystitis (IC) models can be set as intravesical installations of chemical substances such as protamin sulfate, systemic application of chemical substances such as lipopolysaccharides, or environmental stress stimulation like cold, acute/chronic stress models. In the studies regarding IC besides denervation of afferent nerve fibers, several antioxidant agents demonstrated a prominent regeneration as inactivation of mast cells, reconstitution of leaky tight junctions in urothelium. Those agents also prevent formation of reactive oxygen radicals, besides inactivation of afferent nerve fibers containing neurotransmitter like substance P. The chemical agents used in those experimental studies are promising for the future treatment models in IC.

Özet

Deneysel interstisyel sistit (İS) protamin sülfat (PS) gibi kimyasal maddelerin intravezikal verilmesiyle, lipopolisakkarid gibi kimyasal maddelerin sistemik olarak uygulanmasıyla ya da soğuk, akut ve kronik stres gibi sistemik çevresel uyaranlarla oluşturulabilmektedir. Bu İS modellerinde kullanılan bir çok antioksidan ve antienflamatuvar ajanın yanı sıra afferent sinir lifleri denervasyonunun mast hücresi salgılarını inhibe ettiği, mesane duvarında meydana gelen mast hücre degranülasyonunu ve ürotelyum hücreleri arasındaki bağlantıların açılmasını engellediği, P maddesi gibi nörotransmitterleri taşıyan afferent sinirlerin aktivasyonunu ve reaktif oksijen radikallerinin oluşumunu engellediği gösterilmiştir. Yapılan deneysel çalışmalarda iyileştirici etkisi gösterilen kimyasal ajanların İS tedavilerine ışık tutması açısından önemlidir. Anahtar Kelimeler: Deneysel, interstisyel sistit, mast hücresi, enflamasyon, mesane, kimyasal ajanlar

🔖

Cite This Article

ERCAN, F., ÇETİNEL, Ş. (2014). A therapeutic role of chemical agents in experimental interstitial cystitis models. Clinical and Experimental Health Sciences, Cilt: 1 - Sayı: 1, 57–64. https://ajindex.com/articles/481893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Gillenwater JY, Wein AJ. Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987, J Urol 1988; 140:203–206.
  2. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999; 161(2): 549-552.
  3. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993; 149 (3): 465-469.
  4. Johansson S, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 1990; 143 (6): 1118- 1124. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol. 1991; 145 (4): 732-735.
  5. Theoharides TC, Sant GR, El-Mansoury M, Letourneau RJ, Ucci JAA, Meares JEM. Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J Urol. 1995; 153 (3 Pt 1): 629- 636. van de Merwe JP, Nordling J, Bouchelouche P, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC Proposal. Eur Urol. 2008; 53 (1): 60-67.
  6. Christmas TJ, Rode J, Chapple CR, Milroy EJ, Turner-Warwick RT. Nerve fibre proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol. 1990; 416 (5): 447-451.
  7. Pang X, Marchand J, Sant GR, Kream RM, Theoharides TC. Increased number of substance P positive nerve fibers in interstitial cystitis. Br J Urol. 1995; 75(6): 744-750.
  8. Marchand JE, Sant GR, Kream RM. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol. 1998; 81 (2): 224-228.
  9. Ruggieri MR, Hanno PM, Whitmore KE, Balagani RK. Effect of Repeated instillation of interstitial cystitis urine on the rabbit urinary bladder. Urology 1993; 42: 646-652.
  10. Kohn IJ, Filer-Maerten S, Whitmore K E, Hanno PM, Ruggieri MR. Lack of effect following repeated in vivo exposure of the rabbit urinary bladder to urine from interstitial cystitis patients at low infusion volumes. Neurourol Urodyn. 1998; 17: 147-152.
  11. Monson F C, Wein A J, McKenna B A: Indigocarmine as a quantitative indicator of urothelial integrity. J Urol. 1991; 145: 842-845. Shimizu I,